Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Asensus Surgical, Inc. (ASXC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4550+0.0174 (+3.98%)
At close: 04:00PM EDT
0.4719 +0.02 (+3.71%)
After hours: 07:01PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4376
Open0.4447
Bid0.4440 x 1100
Ask0.4800 x 1200
Day's Range0.4200 - 0.4883
52 Week Range0.3500 - 2.3100
Volume1,119,354
Avg. Volume1,380,738
Market Cap113.313M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.3110
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery Program

    System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery Senhance Surgical System Senhance Surgical System RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Clinic for General and Visceral Surgery at the St. Bernhard Hospital in Kamp-Lintfort,

  • GlobeNewswire

    Asensus Surgical Announces Saiseikai Shiga Hospital in Japan to Initiate Senhance Surgery Program

    Senhance Surgical System Senhance Surgical System is the first of its kind digital laparoscopic platform providing surgical assurance through haptic feedback, eye-tracking camera control, 3D visualization and 3mm instruments. RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced

  • GlobeNewswire

    Asensus Surgical Announces Installation of Senhance Surgical System at Evangelical Hospital Goettingen-Weende

    Evangelical Hospital Goettingen-Weende to become 7th Senhance Hospital in Germany Senhance Surgical System The Senhance Surgical System’s open-platform architecture allows for seamless integration of surgeon preference tools, including the 3DHD visualization system. RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Perfo

Advertisement
Advertisement